Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy—given before and after surgery—significantly improved event-free survival (EFS) in patients with resectable …
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer –…
Ruchika Talwar interviews David Morris about changes to Medicare Part D resulting from the Inflation Reduction Act. Dr. Morris discusses how these changes benefit prostate…
Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments…
Zach Klaassen speaks with Todd Morgan about innovative approaches in the management of prostate cancer post-prostatectomy. Dr. Morgan presents compelling new data on the prostate…
Researchers at Wenzhou Medical University in China have discovered that changes in sleep patterns as we age are associated with lower odds of successful aging.
Stanford Medicine researchers and their colleagues tracked the gut, mouth, nose and skin bacteria of 86 people for as long as six years to try…
Alicia Morgans hosts a discussion with Damian Sorce, a urologist, and Manoj Bupathi, a medical oncologist, on their collaboration in treating patients with metastatic hormone-sensitive…
Alicia Morgans sits down with Christos Kyriakopoulos to discuss the findings from the CHAARTED 2 trial. This study builds on the success of the original…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Real World Evidence Evaluating the Underutilization of Treatments for mCRPC in…
In a recent episode of the “Physical Activity Researcher Podcast,” hosted by Dr. Olli Tikkanen, listeners are taken on a deep dive into the world…
